Heyu Biological Technology Corporation
HYBT · OTC
9/30/2025 | 6/30/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $148,023 | $148,023 | $148,023 | $148,022 |
| - Cash | $32 | $50 | $241 | $307 |
| + Debt | $7,091 | $6,944 | $6,798 | $6,487 |
| Enterprise Value | $155,081 | $154,917 | $154,580 | $154,203 |
| Revenue | $3,471 | $3,844 | $46 | $821 |
| % Growth | -9.7% | 8,204.5% | -94.4% | – |
| Gross Profit | $607 | $614 | $33 | $50 |
| % Margin | 17.5% | 16% | 71.4% | 6.1% |
| EBITDA | $451 | $537 | -$202 | -$50 |
| % Margin | 13% | 14% | -435.4% | -6.1% |
| Net Income | $198 | $500 | -$250 | -$61 |
| % Margin | 5.7% | 13% | -539.1% | -7.4% |
| EPS Diluted | 0 | 0.001 | -0.001 | -0 |
| % Growth | -60% | 300% | -400% | – |
| Operating Cash Flow | -$96 | -$230 | -$3,602 | -$3,746 |
| Capital Expenditures | -$416 | -$136 | $12,970 | -$10,856 |
| Free Cash Flow | -$512 | -$365 | $9,368 | -$14,602 |